News & Events | News
Press releases
arGEN-X advances a third therapeutic antibody program into preclinical... read more... BioCapital Europe 2012, Thursday April 19, Bio-Europe Spring 2012, March 19-21, 2012, Amsterdam,... read more... arGEN-X raises EUR 27.5 million (USD 37 million) in... read more... arGEN-X is awarded €1.3 million IWT Grant to Advance... read more... arGEN-X presents significant progress at Biopharm America 2011 ... read more... arGEN-X announces non-exclusive license with BioWa for Potelligent® technology... read more... arGEN-X initiates a second pre-clinical development program in under... read more... arGEN-X signs discovery and development alliance with Lilly ... read more... arGEN-X appoints Dr Debbie Allen as Senior Director Business... read more... |
